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Abstract Information on the prognosis of patients with
transient ischaemic attack or moderately disabling ischae-
mic stroke associated with bilateral internal carotid artery
(ICA) occlusion is scarce. We prospectively studied 57
consecutive patients (46 men; mean age 60 ± 9 years)
with bilateral ICA occlusion who had presented with uni-
lateral transient or moderately disabling cerebral or retinal
ischaemic symptoms. We determined the long-term risk of
recurrent ischaemic stroke and the composite outcome of
stroke, myocardial infarction or vascular death. Four
patients had a recurrent ischaemic stroke during a mean
follow-up of 5.9 years, resulting in an annual stroke rate of
1.2% (95% conﬁdence interval (CI) 0.3–3.1). Risk factors
for recurrent ischaemic stroke could not be identiﬁed.
Eighteen patients suffered a stroke, myocardial infarction
or vascular death, resulting in an annual rate for major
vascular events of 5.3% (95% CI 3.1–8.3). Age and a
history of ischaemic heart disease were signiﬁcant risk
factors for future vascular events. Patients with transient or
moderately disabling symptoms of cerebral or retinal
ischaemia associated with bilateral ICA occlusion have a
relatively low risk of recurrent ischaemic stroke. Although
this study was not designed to compare conservative
treatment with surgical intervention, the favourable out-
come suggests that a policy of medical therapy and control
of risk factors may be justiﬁed in these patients.
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Introduction
A transient ischaemic attack (TIA) or ischaemic stroke is
associated with complete occlusion of one of the internal
carotid arteries (ICA) in about 9% of patients in hospital
based series [13, 20]. In a single study of 2,228 patients
with TIA or stroke only eight patients (0.4%) had bilateral
ICA occlusion [20]. Information on the management and
prognosis of patients with bilateral occlusion of the ICA
is limited by the small numbers of patients studied and
the short duration of follow-up in the majority of studies
[1, 4, 8, 9, 11, 18, 21, 25–27]. Some studies on outcome
of patients with TIA or stroke associated with bilateral
ICA occlusion have emphasized a high risk of recurrent
ischaemic stroke [1, 8, 11] and therefore have recom-
mended surgical revascularization by means of an extra-
cranial–intracranial (EC/IC) bypass or endarterectomy of
an external carotid artery (ECA). In contrast, a meta-
analysis of the outcome of patients with transient or
moderately disabling signs and symptoms associated with
ICA occlusion suggested that patients with a bilateral ICA
occlusion may fare as well or even better than patients
with unilateral ICA occlusion [16]. When confronted with
a patient with symptomatic bilateral ICA occlusion in
clinical practice, information on the risk of new vascular
events is essential to weigh the risks and beneﬁts of
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trol of vascular risk factors, such as revascularization
procedures.
We performed a longitudinal study of a large series of
consecutive patients with bilateral ICA occlusion who had
presented with transient or moderately disabling cerebral or
retinal ischaemia to determine the long-term risk of
recurrent ischaemic stroke and other major vascular out-
come events and to describe haemodynamic characteristics
in relation to the risk of recurrent stroke.
Patients and methods
Patients
We prospectively included consecutive patients who
were referred to the Department of Neurology of the
University Medical Center of Utrecht, The Netherlands,
between January 1990 and February 2007 because of
bilateral ICA occlusion that had caused transient (lasting
\24 h) or at most moderately disabling symptoms of
ischaemia of the eye or brain (modiﬁed Rankin score B3
[3]). Transient ischaemic attack (TIA) or stroke was
deﬁned as the acute onset of neurological deﬁcit, without
signs of haemorrhage on computed tomography (CT)
scan or magnetic resonance imaging (MRI). Ischaemic
symptoms of the eye included transient monocular
blindness, retinal infarction or chronic ocular ischaemia
[5]. The bilateral ICA occlusion (100% obstruction,
deﬁned as absence of contrast ﬁlling of both ICAs) was
preferentially documented by conventional digital sub-
traction angiography. If magnetic resonance angiography
or duplex ultrasonography already had demonstrated the
absence of ﬂow in both ICAs, conventional angiography
was performed only in patients in whom visualisation of
the collateral circulation was important in considering a
surgical revascularization procedure. We excluded
patients with dissection or ICA occlusion associated with
radiation-induced vasculopathy. All patients were inter-
viewed at baseline about their symptoms and about
vascular risk factors as listed in Table 1. This included
speciﬁc questions about symptoms suggestive of a hae-
modynamic origin of TIAs or stroke, e.g. limb-shaking,
retinal claudication or occurrence of TIAs or stroke
subsequent to rising from a sitting or lying position or to
exercise, extensive blood loss, cardiac failure, postpran-
dial hypotension or transition from a cold to warm
environment [17]. We also documented whether patients
continued to suffer from neurological symptoms after
bilateral ICA occlusion had been diagnosed. The study
was approved by the medical ethics committee of the
University Medical Center Utrecht.
Collateral pathways and transcranial Doppler
CO2-reactivity
The presence of stenosis in the subclavian arteries, com-
mon carotid arteries (CCAs), ECAs, vertebral arteries
(VAs), basilar artery, and collateral blood ﬂow pathways
were assessed on the digital subtraction angiograms. The
degree of stenosis was measured according to the NASCET
criteria [10] and dichotomised as a stenosis of C50% or
less than that. Collateral blood ﬂow pathways were studied
for the symptomatic hemisphere. Collateral blood ﬂow via
the ophthalmic artery (OphthA) was considered present if
selective catheterisation of the CCA showed ﬁlling of
intracranial arteries distal from the carotid syphon via the
ECA and OphthA. Collateral blood ﬂow via the posterior
communicating artery (PComA) was considered present if
selective catheterisation of one of the VAs showed ﬁlling
of the anterior cerebral artery (ACA) or middle cerebral
artery (MCA) branches via the PComA. Angiography of
the posterior circulation was also used to study leptome-
ningeal collateral blood supply from the posterior cerebral
artery (PCA) to the vascular territory of the ACA and
MCA.
All patients underwent transcranial Doppler (TCD) with
assessment of the CO2-reactivity to investigate cerebro-
vascular reserve capacity [17]. The CO2-reactivity after
carbogene inhalation was measured as the relative change
in blood ﬂow velocity in the MCA and expressed as a
percentage. A CO2-reactivity of \20% was considered
abnormal, since this value corresponds with the mean CO2-
reactivity minus two times the standard deviation (SD) in
normal controls [14].
Treatment and follow-up
All patients received antithrombotic medication and man-
agement of vascular risk factors. Long-term monitoring of
medication compliance and risk factor control was left to
the general practitioner. Patients with C70% stenosis of the
ECA on the symptomatic side were offered carotid end-
arterectomy (CEA). Patients with frequently recurring
cerebral symptoms and haemodynamic features as descri-
bed above or low TCD CO2-reactivity were offered EC/IC
bypass operation according to the method of Tulleken [15,
23, 24]. Follow-up was performed by telephone interviews
of patients, their relatives or their general practitioners. All
possible events of recurrent ischaemic or haemorrhagic
stroke were veriﬁed by revision of the medical records and
CT scan or MRI of the brain. The primary outcome event
was fatal or non-fatal ischaemic stroke, deﬁned as a new
neurological deﬁcit that persisted for more than 24 h, and
that was not associated with signs of haemorrhage on CT
scan or MRI of the brain. The secondary outcome event
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123was the composite event of fatal or non-fatal ischaemic or
haemorrhagic stroke, myocardial infarction or vascular
death, whichever occurred ﬁrst. Causes of vascular death
included terminal heart failure, sudden death, systemic
bleeding, pulmonary embolism or complications after
vascular surgery.
Data analysis
The annual risks for the primary and secondary outcome
event were calculated, with 95% conﬁdence intervals (CI).
The baseline characteristics as listed in Table 1 were
compared between patients with and without subsequent
ischaemic stroke. The association of vascular risk factors
with the outcome events was assessed by a Cox propor-
tional hazards model and expressed as hazard ratio (HR)
with 95% CI. Risk factors that showed an association with
the outcome event with a p-value\0.15 in the univariable
analysis were included in a multivariable model.
Results
A total of 57 patients (mean age 60, range 42–79 years; 46
men) were included. Thirty-six (63%) patients had pre-
sented with moderately disabling ischaemic stroke, 12
(21%) with cerebral TIA and nine (16%) patients with
retinal ischaemic symptoms only (Table 1). Retinal
ischaemic symptoms included transient monocular blind-
ness in ﬁve, retinal infarction in two and chronic ocular
ischaemic syndrome in two patients. Of the 48 patients
with cerebral ischaemic symptoms, four patients had had
retinal ischaemic symptoms as well. In 36 (63%) of 57
patients the left hemisphere or eye had been symptomatic
Table 1 Baseline characteristics of 57 patients with bilateral ICA occlusion and mean differences in the presence of these characteristics in
patients with (n = 4) and without (n = 53) a recurrent ischaemic stroke
Baseline characteristics All patients Recurrent ischaemic stroke Mean differences
n = 57 Yes: n = 4 No: n = 53
n (%)
a n (%)
a n (%)
a (95% CI)
Age in years (mean ± SD) 60 ± 96 2 ± 96 0 ± 10 2 (-7 to 12)
Male sex 46 (81) 4 (100%) 42 (79%) 21% (-21 to 62)
Cerebral ischaemic symptoms 48 (84) 4 (100%) 44 (83%) 17% (-21 to 55)
Cerebral TIA 12 (21) 2 (50%) 10 (19%)
Cerebral ischaemic stroke 36 (63) 2 (50%) 34 (64%)
Retinal ischaemic symptoms only 9 (16) 0 (0%) 9 (17%)
Haemodynamic symptoms
b 10 (18) 1 (25%) 9 (17%) 8% (-32 to 48)
Limb-shaking 5
Subsequent to rising 0
Subsequent to exercise 2
After transition cold to warm 1
Retinal claudication 2
Other 1
Symptoms after documented bilateral occlusion 23 (40) 2 (50%) 21 (40%) 10% (-41 to 62)
Smoking 46 (81) 4 (100%) 42 (79%) 21% (-21 to 62)
Hyperlipidaemia 44 (77) 2 (50%) 42 (79%) -29% (-73 to 14)
Hypertension 49 (86) 4 (100%) 45 (85%) 15% (-21 to 52)
Diabetes mellitus 13 (23) 1 (25%) 12 (23%) 2% (-42 to 47)
History of ischaemic heart disease 13 (23) 1 (25%) 12 (23%) 2% (-42 to 47)
History of vascular disease in ﬁrst-degree relative 32 (56) 3 (75%) 29 (58%) 17% (-35 to 69)
History of peripheral vascular disease 16 (28) 1 (25%) 15 (28%) -3% (-51 to 44)
CO2-reactivity symptomatic side % (mean ± SD)
c 13 ± 15 12 ± 21 14 ± 15 -2( -18 to 14)
CO2-reactivity asymptomatic side % (mean ± SD)
c 17 ± 18 29 ± 33 15 ± 16 13 (-38 to 64)
Mean differences are differences in proportions with 95% CIs
a Unless otherwise speciﬁed
b One patient had two haemodynamic symptoms. Other haemodynamic symptoms included neurological deﬁcits associated with hypotension in
one patient
c CO2-reactivity was measured on the symptomatic side in 42 and on the asymptomatic side in 43 patients
1730 J Neurol (2009) 256:1728–1735
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patients had had clinical symptoms suggestive of a hae-
modynamic origin, such as limb-shaking or precipitation of
symptoms after rising or exercise. In 23 (40%) of 57
patients neurological symptoms had continued after the
bilateral carotid occlusion had been documented. TCD
CO2-reactivity on the symptomatic side was below 20% in
28 of 42 (67%) patients and on the asymptomatic side in 25
of 43 (58%) patients. None of the patients had a stenosis
C70% of the ECA on the symptomatic side. Two patients
underwent an uncomplicated EC/IC bypass operation and
were censored at the time of operation.
Collateral blood ﬂow patterns
Cerebral angiography was performed in 43 (75%)
patients. The presence of additional lesions in cerebrop-
etal arteries and collateral blood ﬂow patterns are shown
in Table 2. The majority of patients had collateral ﬂow
via the posterior circulation (90%). Twenty-three (70%)
patients had collateral blood ﬂow towards the symptom-
atic hemisphere via the OphthA, but in none of these
patients this was the only collateral blood ﬂow pathway
present. Three patients showed no collateral ﬂow via the
PComA; in one of these a connection was visualised
between the vertebral artery and the distal ICA with
ﬁlling of ACA and MCA branches. In the two other
patients the perfusion of the symptomatic hemisphere was
dependent on ﬂow via the OphthA and leptomeningeal
vessels. The angiogram of three patients showed collateral
ﬂow via the OphthA on the asymptomatic side through
the anterior communicating artery (AComA), with ﬁlling
of the ACA in the symptomatic hemisphere in one patient
and of the ACA and MCA in the symptomatic hemisphere
in two patients (Fig. 1).
Follow-up: primary outcome measure
Mean duration of follow-up was 5.9 years (range
2 months–16.5 years). Of the 57 patients, four (7%) men
had a recurrent ischaemic stroke, which was fatal in 2
patients. The corresponding annual stroke rate was 1.2%
(95% CI 0.3–3.1). Table 1 summarises the baseline
characteristics of patients with and without a recurrent
ischaemic stroke. Of the four patients with recurrent
stroke, none had presented with only retinal ischaemic
symptoms. One of the four patients had presented with
symptoms suggestive of a haemodynamic origin. Two of
the patients with recurrent stroke had had ongoing neu-
rological symptoms after the bilateral ICA occlusion had
been documented. TCD CO2-reactivity on the symptom-
atic or asymptomatic side did not differ between patients
with and without recurrent stroke. Table 3 shows the
clinical characteristics and the type of collateral pathways
utilised at baseline of the four patients with recurrent
ischaemic stroke. Because of the small number of recur-
rent ischaemic strokes, Cox proportional hazards model-
ling of possible determinants of recurrent ischaemic
stroke, including the type of collateral pathways and TCD
CO2-reactivity could not be performed.
Table 2 Description of additional lesions of cerebropetal arteries on the angiograms (n = 43), and of collateral blood ﬂow patterns
All patients n = 43
Additional lesions cerebropetal arteries (n)
CCA stenosis 2/0
a
Occlusion 4/4
a
ECA stenosis 2/7
a
Occlusion 1/1
a
VA unilateral stenosis 16
Unilateral occlusion 2
Collateral blood ﬂow pathways
b n (%) Only ACA Only MCA ACA ? MCA
PComA 26 (90) 0 8 18
AComA (via contralateral OphthA) 3 (9) 1 0 2
OphthA 23 (70) 2 7 14
Leptomeningeal 14 (42)
a On the symptomatic side/asymptomatic side
b Collateral blood ﬂow towards the symptomatic hemisphere via the PComA could be assessed in 29 patients, via the AComA in 34 patients and
via the OphthA and leptomeningeal vessels in 33 patients. Collateral blood ﬂow is further speciﬁed for ﬁlling of only ACA, only MCA or both
ACA and MCA branches
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old man with bilateral ICA
occlusion with collateral blood
ﬂow towards the left
symptomatic hemisphere via the
OphthA on the asymptomatic
side, who did not suffer a
recurrent ischaemic stroke
during a follow-up period of
3.2 years; a bilateral ICA
occlusion; b selective
catheterisation of the left CCA
shows ﬁlling of only a few
MCA branches via the OphthA;
c selective catheterisation of the
right CCA shows extensive
ﬁlling of ACA and MCA
branches in the right hemisphere
and d of the left hemisphere via
the right OphthA and
subsequently the AComA with
ﬁlling of ACA and MCA
branches
Table 3 Characteristics of the four patients with recurrent ischaemic stroke
Patient 1 Patient 2 Patient 3 Patient 4
Subsequent infarction Fatal ipsilateral Non-fatal contralateral
PCA territory
Non-fatal ipsilateral Fatal contralateral
Time interval between inclusion and
recurrent stroke (months)
18 23 30 115
Other comorbidities at the time
of recurrent stroke
Gastric bleeding - Atrial ﬁbrillation -
Additional stenosis or occlusion
on angiogram at baseline
VA occlusion ECA 50%
a CCA occlusion
a CCA 50%
b
VA 90% VA 50%
Collateral ﬂow via PComA ?? ? Not visualised
Collateral ﬂow via OphthA ?- - ?
Leptomeningeal vessels -? - Not visualised
CO2-reactivity symptomatic side % 0 -44 2 1 1
CO2-reactivity asymptomatic side % 4 4 73 32
a On the asymptomatic side
b On the symptomatic side
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123Follow-up: secondary outcome measure
Eighteen (32%) patients had an ischaemic or haemorrhagic
stroke, myocardial infarction or died from a vascular cause,
corresponding to an annual event rate of 5.3% (95% CI
3.1–8.3). In addition to four ischaemic strokes, four
patients suffered from an intracerebral haemorrhage (fatal
in three) and four patients had non-fatal myocardial
infarction. Other vascular causes of death apart from stroke
were cardiac failure in two patients, sudden death in three
patients and complications after peripheral vascular sur-
gery in one patient. The intracerebral haemorrhage was
located in the basal ganglia with intraventricular extension
in three patients and in the fourth patient the diagnosis was
based on the symptoms of acute headache, vomiting and a
hemiparesis followed by death. Age (HR 1.07, 95% CI
1.01–1.14) and a history of ischaemic heart disease (HR
3.6, 95% CI 1.3–10) were associated with the secondary
outcome measure (Table 4). In a multivariable analysis
including age, hypertension and a history of ischaemic
heart disease, the HR for the composite endpoint associated
with age was 1.06 (95% CI 0.99–1.12) and for a history of
ischaemic heart disease 2.4 (95% CI 0.8–6.8).
Discussion
This largest longitudinal study to date of patients with
bilateral carotid occlusion presenting with transient or
moderately disabling symptoms of cerebral or retinal
ischaemia shows a relatively low risk of recurrent ischae-
mic stroke. We could not identify determinants of the risk
of recurrent stroke. Age and a history of ischaemic heart
disease are risk factors for major vascular events in general
(any stroke, myocardial infarction or vascular death).
The previously reported annual stroke rates in patients
with bilateral ICA occlusion range between 0 and 13%
[1, 4, 8, 9, 11, 18, 21, 25, 26]. The largest prospective
follow-up study on bilateral ICA occlusion with non- or
moderately disabling symptoms so far was published more
than 20 years ago and consisted of 34 patients, of whom 11
patients suffered a stroke during a mean duration of follow-
up of 3.5 years [26]. That the annual stroke rate in our
study was comparatively low may be partly attributed to
the relatively large proportion of patients with retinal
ischaemic symptoms included in our study; it has been
found before that patients with unilateral occlusion and
only symptoms of retinal ischaemia have a lower risk of
recurrent stroke than those with cerebral ischaemic symp-
toms [12, 17]. Another explanation may be that medical
treatment for secondary prevention of stroke and control of
vascular risk factors is currently more effective than two or
three decades earlier. Most other follow-up studies found
annual stroke rates between 0 and 6%, which is more in
agreement with our ﬁndings. However, these included only
a small number of patients (between 8 and 21) [1, 18, 21,
25] or described only patients who underwent an EC/IC
bypass operation [8] or various revascularization opera-
tions including EC/IC bypass [11].
It has been suggested that in patients with bilateral ICA
occlusion who survive without major stroke, the collateral
blood ﬂow pathways are particularly efﬁcient and maintain
cerebral perfusion [25]. We found extensive collateral
blood ﬂow patterns in the symptomatic hemisphere in the
majority of patients, including the patients who later on had
a recurrent stroke. Although the low event rate did not
allow a formal analysis of collateral pathways as determi-
nants of recurrent stroke, we found that subsequent
infarction occurred not only in patients with additional
collateral blood ﬂow via the OphthA or leptomeningeal
blood vessels, which are considered secondary pathways
[19] but also in patients with collateral blood ﬂow via the
PComA without collateral blood ﬂow via secondary path-
ways. In addition, not all patients with only secondary
Table 4 Univariable relation of
patient characteristics to the
composite outcome event of
ischaemic or haemorrhagic
stroke, myocardial infarction or
vascular death, expressed in
hazard ratios (HR) with 95%
CIs
Patient characteristics Stroke, myocardial infarction
or vascular death during
follow-up (n%)
HR (95% CI)
Yes (n = 18) No (n = 39)
Age in years (mean ± SD) 62 ± 85 9 ± 10 1.07 (1.01–1.14)
Male sex 17 (94%) 29 (74%) 3.8 (0.5–29)
Smoking 13 (72%) 33 (85%) 0.5 (0.2–1.4)
Hyperlipidaemia 13 (72%) 31 (80%) 0.8 (0.3–2.3)
Hypertension 17 (94%) 32 (82%) 5.4 (0.7–43)
Diabetes 3 (17%) 10 (26%) 0.9 (0.3–3.3)
History of ischaemic heart disease 7 (39%) 6 (15%) 3.6 (1.3–10)
History of vascular disease in ﬁrst-degree relative 11 (65%) 21 (57%) 1.3 (0.5–3.5)
History of peripheral vascular disease 5 (28%) 11 (28%) 1.1 (0.4–3.2)
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123collateral pathways suffered a recurrent ischaemic stroke.
In line with our results, two previous studies of patients
with bilateral ICA occlusion also failed to ﬁnd an associ-
ation between the type of collateral blood ﬂow pathways
and recurrent stroke [26, 27]. We hypothesise that to sur-
vive bilateral ICA occlusion without major stroke, exten-
sive collateral blood ﬂow pathways must already have
developed at the time of ﬁrst presentation. This view may
be supported by the results of a subgroup analysis of the
Asymptomatic Carotid Atherosclerosis Study (ACAS), in
which medically treated asymptomatic patients with a
stenosis of the ICA of 60% or more and a contralateral ICA
occlusion had a lower risk of death (during ﬁrst 30 days)
and stroke (cumulative 5-year rate 3.5%) than patients
without contralateral ICA occlusion (cumulative 5-year
rate 11.7%) [2].
Since the presence of bilateral ICA occlusion is a sign of
very severe atherosclerotic disease, a high rate of other
vascular events can be expected. In agreement with other
studies, [18, 25] we found that indeed recurrent ischaemic
stroke made up only a modest proportion of the vascular
events that occurred during the time of follow-up. In pre-
vious follow-up studies the risk of stroke, myocardial
infarction or vascular death in patients who were not
selected because of carotid disease, amounted to 4% per
year in patients who were followed for a mean of 10 years
after TIA [6] and a cumulative 5-year risk of 29% after ﬁrst
ischaemic stroke [7]. Another study of 2,739 patients with
TIA or moderately disabling stroke treated with aspirin or
the combination of aspirin and dipyridamole during a mean
follow-up time of 3.5 years found an annual risk of stroke,
myocardial infarction or vascular death between 3% and
4% [22]. Against this background, symptomatic bilateral
occlusion in our series is associated with a comparable
event rate of 5.3%.
This study has some limitations. First, the study cohort
consisted of patients from all over the Netherlands, who
were referred to a single tertiary university hospital and
therefore referral bias most probably plays a role. How-
ever, patients with frequent and ongoing symptoms will
probably have been more readily referred than those with
only one event and no further symptoms. In that case, the
risk of recurrent stroke that we report would rather be
overestimated than underestimated. Second, follow-up was
performed by telephone interviews instead of regular hos-
pital visits and events that had only a minor impact on the
patient’s abilities may have been missed. Third, all patients
were advised about the control of vascular risk factors, but
we did not obtain information on how well vascular risk
factors were indeed controlled in individual patients.
However, despite possible non-compliance with medica-
tion we found a relatively low risk of recurrent ischaemic
stroke. Fourth, two patients were censored at the time of an
EC/IC bypass operation that was advised because of
ongoing TIAs. It is uncertain whether these patients might
have had an ischaemic stroke if they had not been operated.
In conclusion, this study shows that patients with tran-
sient or moderately disabling cerebral or retinal ischaemic
symptoms associated with bilateral ICA occlusion have a
relatively low risk of recurrent ischaemic stroke and a risk
of any major vascular event that is comparable to this risk
in patients with TIA or stroke in general. Although this
study was not designed to compare conservative treatment
with surgical intervention, our observations suggest that a
policy of medical therapy and control of risk factors may
be justiﬁed in these patients.
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